[HTML][HTML] Lipoprotein (a): an underestimated inflammatory mastermind

KE Dzobo, JM Kraaijenhof, ESG Stroes… - Atherosclerosis, 2022 - Elsevier
Abstract Lipoprotein (a)[Lp (a)] has been established as an independent and causal risk
factor for cardiovascular disease. Individuals with elevated levels of Lp (a)(> 125 nmol/L;> …

Lipoprotein (a) and its potential association with thrombosis and inflammation in COVID-19: a testable hypothesis

PM Moriarty, LK Gorby, ES Stroes, JP Kastelein… - Current atherosclerosis …, 2020 - Springer
Abstract Purpose of Review The COVID-19 pandemic has infected over> 11 million as of
today people worldwide and is associated with significant cardiovascular manifestations …

Association between COVID-19 diagnosis and coronary artery thrombosis: a narrative review

F Nappi, O Giacinto, O Ellouze, A Nenna… - Biomedicines, 2022 - mdpi.com
Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

Lipoprotein apheresis: first FDA indicated treatment for elevated lipoprotein (a)

AK Nugent, JV Gray, LK Gorby… - Journal of Clinical …, 2020 - scientificarchives.com
Background: Elevated lipoprotein (a)[Lp (a)] is an independent risk factor for cardiovascular
disease (CVD) for which no commercially available pharmacotherapy exists. Currently …

The lipid paradox in neuroprogressive disorders: causes and consequences

G Morris, M Berk, K Walder, A O'Neil, M Maes… - Neuroscience & …, 2021 - Elsevier
Chronic systemic inflammation is associated with an increased risk of cardiovascular
disease in an environment of low low-density lipoprotein (LDL) and low total cholesterol and …

[HTML][HTML] Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes

C Buechler, H Ullrich, C Aslanidis, SM Bared… - … et Biophysica Acta (BBA …, 2003 - Elsevier
The association of elevated lipoprotein (a)(Lp (a)) with an increased risk for coronary events
is clearly established. This increased risk may in part be due to the activation of monocytes …

[HTML][HTML] Familial hypercholesterolemia and COVID-19: a menacing but treatable vasculopathic condition

A Vuorio, TE Strandberg, F Raal, RD Santos… - Atherosclerosis …, 2021 - Elsevier
SARS-CoV-2 infection continues to cause increased morbidity and mortality, and due to the
slow pace of vaccination COVID-19 will probably remain a global burden to health systems …

Lipoprotein (a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery

G Chimienti, F Aquilino, MT Rotelli… - Journal of British …, 2006 - academic.oup.com
Background The aims were to investigate whether surgical stress can induce a positive or
negative lipoprotein (a) acute response, to determine any association with apolipoprotein (a) …

[PDF][PDF] Association between COVID-19 diagnosis and coronary artery thrombosis: a narrative review. biomedicines 2022; 10: 702

F Nappi, O Giacinto, O Eliouse - 2022 - academia.edu
Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

[图书][B] Der apo (a)-Polymorphismus und Lipoprotein (a)-Spezifitäten beim terminal Niereninsuffizienten, experimentelle Identifizierung neuer Phänotypen, Analyse der …

H Cura - 2010 - search.proquest.com
Methoden: Wir untersuchten ein vergleichsweise großes Kollektiv von 251 Dialysepatienten,
HD n= 210, PD n= 41, und bestimmten Lp (a)–Spiegel mittels ELISA (Immuno) unter …